Vice President of Specialty Oncology, Franchise Leader

<div class="content-intro"><p><span style="font-family: times new roman, times, serif;"><span style="font-size: 16px;"> </span></span></p></div><p><span style="font-family: 'times new roman', times, serif; font-size: 12pt;">CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.</span></p> <p><span style="font-size: 12pt; font-family: 'times new roman', times, serif;">The VP of Specialty Oncology role serves as the Franchise Leader for NavDx across Head & Neck, GI, and Gynecologic cancers, with full accountability for strategy, brand marketing, market shaping, and pipeline. This leader owns the commercial and medical education ecosystem for NavDx, driving adoption, clinical integration, and long-term franchise value, while orchestrating upstream marketing (product lifecycle management, indication expansion), downstream marketing (brand strategy, targeting, messaging, selling directions), Medical Education, KOL engagement.</span></p> <h2><span style="font-size: 12pt; font-family: 'times new roman', times, serif;">Core Accountabilities</span></h2> <h3><span style="font-size: 12pt; font-family: 'times new roman', times, serif;">Franchise Strategy & P&L Ownership</span></h3> <ul> <li style="font-size: 12pt; font-family: 'times new roman', times, serif;"><span style="font-size: 12pt; font-family: 'times new roman', times, serif;">Own the integrated franchise strategy across HPV-driven cancers aligned to long-term growth</span></li> <li style="font-size: 12pt; font-family: 'times new roman', times, serif;"><span style="font-size: 12pt; font-family: 'times new roman', times, serif;">Accountable for volume, revenue, and market share performance</span></li> <li style="font-size: 12pt; font-family: 'times new roman', times, serif;"><span style="font-size: 12pt; font-family: 'times new roman', times, serif;">Translate clinical evidence and market insights into strategic priorities and investments</span></li> <li style="font-size: 12pt; font-family: 'times new roman', times, serif;"><span style="font-size: 12pt; font-family: 'times new roman', times, serif;">Shape lifecycle expansion, new indications, and guideline inclusion strategies</span></li> </ul> <h3><span style="font-size: 12pt; font-family: 'times new roman', times, serif;">Market Shaping & Disease Leadership</span></h3> <ul> <li style="font-size: 12pt; font-family: 'times new roman', times, serif;"><span style="font-size: 12pt; font-family: 'times new roman', times, serif;">Lead market shaping strategies to redefine standards of care in surveillance and MRD monitoring</span></li> <li style="font-size: 12pt; font-family: 'times new roman', times, serif;"><span style="font-size: 12pt; font-family: 'times new roman', times, serif;">Partner with Medical Affairs to develop evidence generation and publication strategy that supports guideline inclusion, clinical adoption and payer coverage</span></li> <li style="font-size: 12pt; font-family: 'times new roman', times, serif;"><span style="font-size: 12pt; font-family: 'times new roman', times, serif;">Establish NavDx as the reference standard across academic and community settings</span></li> </ul> <h3><span style="font-size: 12pt; font-family: 'times new roman', times, serif;">